MIF
REGN icon

Mediolanum International Funds’s Regeneron Pharmaceuticals REGN Stock Holding History

Mediolanum International Funds’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.32M Sell
14,754
-56,455
-79% -$38.4M 0.08% 233
2026
Q1 		$53.4M Buy
71,209
+25,674
+56% +$19.7M 0.57% 33
2025
Q4 		$35.2M Buy
45,535
+44,280
+3,528% +$30.1M 0.35% 61
2025
Q3 		$704K Sell
1,255
-2,336
-65% -$1.32M 0.01% 390
2025
Q2 		$1.87M Sell
3,591
-29,629
-89% -$16.5M 0.02% 340
2025
Q1 		$21.2M Buy
33,220
+28,771
+647% +$19.8M 0.29% 81
2024
Q4 		$3.12M Buy
4,449
+224
+5% +$188K 0.04% 286
2024
Q3 		$4.4M Sell
4,225
-10,517
-71% -$11.7M 0.06% 260
2024
Q2 		$14.5M Buy
14,742
+1,876
+15% +$1.82M 0.24% 88
2024
Q1 		$12.4M Buy
+12,866
New +$12.2M 0.2% 112

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mediolanum International Funds's REGN Position: Q2 2026 in Review

Mediolanum International Funds reduced its Regeneron Pharmaceuticals (REGN) stake by 79% in Q2 2026, selling an estimated $38.4M and leaving 14,754 shares worth $9.32M. The position accounts for 0.08% of the portfolio, ranked #233.

Mediolanum International Funds first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $53.4M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Mediolanum International Funds held 14,754 shares of Regeneron Pharmaceuticals worth $9.32M as of Q2 2026.
  • Mediolanum International Funds sold 56,455 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $38.4M.
  • Regeneron Pharmaceuticals made up 0.08% of Mediolanum International Funds's portfolio in Q2 2026, its #233 holding.
  • Mediolanum International Funds first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Regeneron Pharmaceuticals position peaked at $53.4M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.